Selected Abstracts

Accurate Risk Assessment for the Development of PML in Natalizumab Treated MS Patients Requires CSF Analysis

Peggy Bettin, Jerry Lin, and Saud A. Sadiq. Presented at the 2012 annual meeting of the American Academy of Neurology, held April 23-27 in New Orleans, LA.

Read Abstract

Neuroketals in the cerebrospinal fluid of multiple sclerosis patients

Donald Lee, Fozia Mir and Saud Sadiq. Presented at the 2012 annual meeting of the American Academy of Neurology, held April 23-27 in New Orleans, LA.

Read Abstract

Cerebrospinal fluid derived from progressive multiple sclerosis patients promotes neuronal and oligodendroglial differentiation of human neural precursor cells in vitro

Barbara Cymring, Massimiliano Cristofanilli, Amy Lu, Hannah Rosenthal, and Saud A. Sadiq. Presented at the 2012 annual meeting of the American Academy of Neurology, held April 23-27 in New Orleans, LA.

Read Abstract

Lipid peroxidation products as novel biomarkers in the cerebrospinal fluid of Multiple Sclerosis patients

Fozia Mir. Presented at the annual meeting of the American Society of Neurochemistry held March 3-7 in Baltimore, MD.

Read Abstract

MS disease activity inhibits hepatocyte growth factor (HGF) production within the CNS - a new putative mechanism contributing to lack of lesion repair seen in MS

A.M. Mueller, E. Jun, H. Conlon, S. Sadiq. Nov 14th 2011. Platform presentation at the 2011 meeting of the Society for Neuroscience, Washington DC, USA.

Read Abstract

Human mesenchymal stem cell-derived neural progenitors (MSC-NPs) exhibit trophic properties that may influence repair in MS

Raihan Faroqui, Violaine K. Harris, Tamara Vyshkina, and Saud A. Sadiq. Presented at the 5th joint congress of ECTRIMS and ACTRIMS meeting held October 19-22, 2011 in Amsterdam.

Read Abstract

CSF biomarker profiles of MS patients treated with intrathecal methotrexate (ITMTX)

Amir Touray, Violaine K. Harris, and Saud A. Sadiq. Presented at the 5th joint congress of ECTRIMS and ACTRIMS meeting held October 19-22, 2011 in Amsterdam.

Read Abstract

Intrathecal methotrexate (ITMTX) reduces astrogliosis in a non-inflammatory demyelination model

Hana Conlon, André Müller, Xinhe Liu , Esther Jun, Saud Sadiq. Presented at the 5th joint congress of ECTRIMS and ACTRIMS meeting held October 19-22, 2011 in Amsterdam.

Read Abstract

Elevated cerebrospinal fluid levels of an isoprostane, an oxidative stress biomarker in MS patients

Fozia Mir and Saud A. Sadiq. Presented at the 5th joint congress of ECTRIMS and ACTRIMS meeting held October 19-22, 2011 in Amsterdam.

Read Abstract

Safety of Long-term Intrathecal Methotrexate Therapy in Progressive Forms of Multiple Sclerosis

James W. Stark, MD, Laura Leuenberger and Saud A. Sadiq, MD. Presented at the 5th joint congress of ECTRIMS and ACTRIMS meeting held October 19-22, 2011 in Amsterdam.

Read Abstract

Pages

Tisch MS Research Center of New York

521 West 57th Street
4th Floor
New York, NY 10019
(646) 557-3900

Privacy Policy

 

Support Tisch MS

Support Tisch MS and our innovative research leading to treatments that improve the lives of patients.